PTN Stock Analysis: Buy, Sell, or Hold?
$10.16
0.47 (4.85%)
▲
5d:
+2.11%
30d:
+31.86%
90d:
-31.7%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 26, 2026
1d
Get Alerted When PTN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: PTN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: PTN shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: PTN is currently trading at $10.16, which is considered extended relative to its 30-day fair value range of $7.65 to $9.62.
Technical Outlook: Technically, PTN is in a strong downtrend. Immediate support is located at $7.27, while resistance sits at $11.13. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: PTN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $53.50 (+424.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PTN is in a strong downtrend. Immediate support is located at $7.27, while resistance sits at $11.13. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: PTN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $53.50 (+424.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$7.65 -
$9.62
Company Quality Score
25/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range (+5.6% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.9%)
- BULLISH: Trading 424.5% below Wall St target ($53.50)
- WARNING: Composite score 25/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$7.65 -
$9.62
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$7.27
Resistance Level
$11.13
Current Trend
Strong Downtrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.20
Wall Street Target
$53.50
(+424.5%)
Revenue Growth (YoY)
-80.1%
Profit Margin
-48.5%
Share & Embed Analysis
Last updated: August 24, 2026 4:40 PM ET
Data refreshes hourly during market hours. Next update: 5:40 PM
Data refreshes hourly during market hours. Next update: 5:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PTN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 62 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 53 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 37 SELL |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 47 HOLD |